Combio Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Combio General Information

Description

Developer of novel synthesis and screening technologies. The company focuses in discovery and optimization of drug candidates against therapeutically important protease and protease reagents and protease characterization. It is based on proprietary bead-based lead optimization tools and chemical scaffolds for novel protease inhibitors. In addition, it has in-house in vitro pharmacology, medicinal chemistry, computational chemistry and intellectual property rights management.

Contact Information

Website
www.combio.biz
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Vesterbrogade 188 / Frydendalsvej 32
  • 1800 Frederiksberg
  • Denmark
+45 70
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Arpida
Vertical(s)
Life Sciences
Corporate Office
  • Vesterbrogade 188 / Frydendalsvej 32
  • 1800 Frederiksberg
  • Denmark
+45 70

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Combio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 15-Oct-2004 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view Combio’s complete valuation and funding history, request access »

Combio Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Carlsberg Corporation Minority
DKA Capital PE/Buyout Minority
Lønmodtagernes Dyrtidsfond Fonde Limited Partner Minority
Novo Holdings Venture Capital Minority
Scandinavian Life Science Venture Venture Capital Minority
To view Combio’s complete investors history, request access »

Ready to get started?

Request a free trial

Combio FAQs

  • When was Combio founded?

    Combio was founded in 2000.

  • Where is Combio headquartered?

    Combio is headquartered in Frederiksberg, Denmark.

  • What industry is Combio in?

    Combio’s primary industry is Drug Discovery.

  • Is Combio a private or public company?

    Combio is a Private company.

  • What is Combio’s current revenue?

    The current revenue for Combio is .

  • Who are Combio’s investors?

    Carlsberg, DKA Capital, Lønmodtagernes Dyrtidsfond Fonde, Novo Holdings, and Scandinavian Life Science Venture have invested in Combio.

  • When was Combio acquired?

    Combio was acquired on 15-Oct-2004.

  • Who acquired Combio?

    Combio was acquired by Arpida.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process